Company: DAWN
Filing Date: 2025-02-25
Form Type: 8-K
Source: 0000950170-25-026632
Chunk: 0

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-02-25
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

On February 25, 2025, Day One Biopharmaceuticals, Inc. (the "Company") issued a press release announcing its financial results for the quarter and year ended December 31, 2024. A copy of the press release is attached as Exhibit 99.1 to this report. A copy of the Company’s presentation with respect to its financial results for the quarter and year ended December 31, 2024 is attached as Exhibit 99.2 to this report.

Item 7.01 Regulation FD Disclosure.